Annual gross profit:
$34.33B+$19.00M(+0.06%)Summary
- As of today (April 16, 2025), BMY annual gross profit is $34.33 billion, with the most recent change of +$19.00 million (+0.06%) on December 1, 2024.
- During the last 3 years, BMY annual gross profit has fallen by -$2.11 billion (-5.80%).
- BMY annual gross profit is now -5.80% below its all-time high of $36.45 billion, reached on December 31, 2021.
Performance
BMY Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$7.53B-$1.41B(-15.72%)Summary
- As of today (April 16, 2025), BMY quarterly gross profit is $7.53 billion, with the most recent change of -$1.41 billion (-15.72%) on December 1, 2024.
- Over the past year, BMY quarterly gross profit has dropped by -$1.20 billion (-13.77%).
- BMY quarterly gross profit is now -21.80% below its all-time high of $9.63 billion, reached on December 31, 2021.
Performance
BMY quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$34.33B-$1.20B(-3.38%)Summary
- As of today (April 16, 2025), BMY TTM gross profit is $34.33 billion, with the most recent change of -$1.20 billion (-3.38%) on December 1, 2024.
- Over the past year, BMY TTM gross profit has increased by +$19.00 million (+0.06%).
- BMY TTM gross profit is now -8.18% below its all-time high of $37.39 billion, reached on March 31, 2022.
Performance
BMY TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
BMY Gross profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.1% | -13.8% | +0.1% |
| 3 y3 years | -5.8% | -13.8% | +0.1% |
| 5 y5 years | +90.0% | -13.8% | +0.1% |
BMY Gross profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5.8% | +0.1% | -17.9% | at low | -8.2% | +0.1% |
| 5 y | 5-year | -5.8% | +90.0% | -21.8% | +5.8% | -8.2% | +62.8% |
| alltime | all time | -5.8% | +533.8% | -21.8% | +407.8% | -8.2% | +1786.4% |
Bristol-Myers Squibb Gross profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $34.33B(+0.1%) | $7.53B(-15.7%) | $34.33B(-3.4%) |
| Sep 2024 | - | $8.94B(+0.0%) | $35.53B(+1.4%) |
| Jun 2024 | - | $8.93B(+0.0%) | $35.06B(+1.7%) |
| Mar 2024 | - | $8.93B(+2.3%) | $34.48B(+0.5%) |
| Dec 2023 | $34.31B(-4.7%) | $8.73B(+3.2%) | $34.31B(-0.2%) |
| Sep 2023 | - | $8.46B(+1.3%) | $34.39B(-1.2%) |
| Jun 2023 | - | $8.35B(-4.8%) | $34.80B(-2.3%) |
| Mar 2023 | - | $8.77B(-0.5%) | $35.62B(-1.1%) |
| Dec 2022 | $36.02B(-1.2%) | $8.81B(-0.6%) | $36.02B(-2.2%) |
| Sep 2022 | - | $8.87B(-3.3%) | $36.84B(-1.3%) |
| Jun 2022 | - | $9.17B(-0.1%) | $37.31B(-0.2%) |
| Mar 2022 | - | $9.18B(-4.7%) | $37.39B(+2.6%) |
| Dec 2021 | $36.45B(+18.5%) | $9.63B(+3.2%) | $36.45B(+4.2%) |
| Sep 2021 | - | $9.33B(+0.9%) | $34.97B(+3.8%) |
| Jun 2021 | - | $9.25B(+12.4%) | $33.68B(+5.7%) |
| Mar 2021 | - | $8.23B(+0.9%) | $31.86B(+3.6%) |
| Dec 2020 | $30.75B(+70.2%) | $8.16B(+1.5%) | $30.75B(+9.6%) |
| Sep 2020 | - | $8.04B(+8.2%) | $28.04B(+15.8%) |
| Jun 2020 | - | $7.43B(+4.4%) | $24.22B(+14.8%) |
| Mar 2020 | - | $7.12B(+30.6%) | $21.09B(+16.7%) |
| Dec 2019 | $18.07B(+12.3%) | $5.45B(+29.3%) | $18.07B(+6.4%) |
| Sep 2019 | - | $4.22B(-2.0%) | $16.98B(+1.0%) |
| Jun 2019 | - | $4.30B(+5.0%) | $16.80B(+1.3%) |
| Mar 2019 | - | $4.10B(-6.1%) | $16.58B(+3.0%) |
| Dec 2018 | $16.09B(+9.0%) | $4.36B(+7.9%) | $16.09B(+3.3%) |
| Sep 2018 | - | $4.04B(-0.9%) | $15.58B(+2.4%) |
| Jun 2018 | - | $4.08B(+13.0%) | $15.21B(+3.4%) |
| Mar 2018 | - | $3.61B(-6.2%) | $14.71B(-0.4%) |
| Dec 2017 | $14.76B(+2.1%) | $3.85B(+4.7%) | $14.76B(+0.1%) |
| Sep 2017 | - | $3.67B(+2.8%) | $14.75B(+0.4%) |
| Jun 2017 | - | $3.58B(-2.4%) | $14.69B(-0.6%) |
| Mar 2017 | - | $3.66B(-4.5%) | $14.78B(+2.2%) |
| Dec 2016 | $14.46B(+14.3%) | $3.84B(+6.1%) | $14.46B(+3.6%) |
| Sep 2016 | - | $3.62B(-1.3%) | $13.96B(+4.8%) |
| Jun 2016 | - | $3.67B(+9.8%) | $13.31B(+4.0%) |
| Mar 2016 | - | $3.34B(+0.1%) | $12.80B(+1.1%) |
| Dec 2015 | $12.65B(+5.9%) | $3.33B(+12.2%) | $12.65B(+0.3%) |
| Sep 2015 | - | $2.97B(-5.7%) | $12.61B(+0.5%) |
| Jun 2015 | - | $3.15B(-1.4%) | $12.55B(+2.0%) |
| Mar 2015 | - | $3.19B(-3.0%) | $12.30B(+2.9%) |
| Dec 2014 | $11.95B(+1.5%) | $3.29B(+13.0%) | $11.95B(+1.0%) |
| Sep 2014 | - | $2.91B(+0.6%) | $11.82B(+0.2%) |
| Jun 2014 | - | $2.90B(+1.9%) | $11.80B(-0.4%) |
| Mar 2014 | - | $2.84B(-10.3%) | $11.84B(+0.6%) |
| Dec 2013 | $11.77B(-9.6%) | $3.17B(+9.6%) | $11.77B(+0.4%) |
| Sep 2013 | - | $2.89B(-1.7%) | $11.71B(+1.2%) |
| Jun 2013 | - | $2.94B(+6.2%) | $11.57B(-2.2%) |
| Mar 2013 | - | $2.77B(-11.2%) | $11.83B(-9.1%) |
| Dec 2012 | $13.01B(-16.8%) | $3.12B(+13.4%) | $13.01B(-6.9%) |
| Sep 2012 | - | $2.75B(-14.0%) | $13.98B(-7.8%) |
| Jun 2012 | - | $3.20B(-19.0%) | $15.17B(-4.7%) |
| Mar 2012 | - | $3.95B(-3.4%) | $15.93B(+1.8%) |
| Dec 2011 | $15.65B(+10.1%) | $4.09B(+3.8%) | $15.65B(+2.6%) |
| Sep 2011 | - | $3.94B(-0.4%) | $15.26B(+2.8%) |
| Jun 2011 | - | $3.95B(+7.8%) | $14.84B(+3.2%) |
| Mar 2011 | - | $3.67B(-0.8%) | $14.37B(+1.2%) |
| Dec 2010 | $14.21B(+3.9%) | $3.70B(+5.1%) | $14.21B(+0.7%) |
| Sep 2010 | - | $3.52B(+0.8%) | $14.11B(+0.3%) |
| Jun 2010 | - | $3.49B(-0.3%) | $14.06B(+0.4%) |
| Mar 2010 | - | $3.50B(-2.8%) | $14.01B(+2.5%) |
| Dec 2009 | $13.67B(+10.2%) | $3.60B(+3.7%) | $13.67B(+14.0%) |
| Sep 2009 | - | $3.47B(+0.9%) | $11.99B(-1.2%) |
| Jun 2009 | - | $3.44B(+9.0%) | $12.14B(-0.8%) |
| Mar 2009 | - | $3.16B(+64.0%) | $12.23B(-1.3%) |
| Dec 2008 | $12.40B(-5.6%) | $1.93B(-46.8%) | $12.40B(-15.2%) |
| Sep 2008 | - | $3.62B(+2.5%) | $14.62B(+3.5%) |
| Jun 2008 | - | $3.53B(+6.4%) | $14.12B(+3.4%) |
| Mar 2008 | - | $3.32B(-19.9%) | $13.65B(+2.6%) |
| Dec 2007 | $13.13B | $4.15B(+32.8%) | $13.31B(+15.9%) |
| Sep 2007 | - | $3.12B(+2.0%) | $11.49B(+3.9%) |
| Jun 2007 | - | $3.06B(+2.9%) | $11.05B(-2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $2.98B(+28.0%) | $11.29B(-1.9%) |
| Dec 2006 | $11.52B(-10.5%) | $2.33B(-13.5%) | $11.52B(-5.6%) |
| Sep 2006 | - | $2.69B(-18.6%) | $12.21B(-4.6%) |
| Jun 2006 | - | $3.30B(+3.2%) | $12.80B(-0.8%) |
| Mar 2006 | - | $3.20B(+6.2%) | $12.90B(+0.3%) |
| Dec 2005 | $12.87B(-3.9%) | $3.01B(-8.3%) | $12.87B(-3.6%) |
| Sep 2005 | - | $3.28B(-3.6%) | $13.35B(-0.2%) |
| Jun 2005 | - | $3.41B(+7.6%) | $13.37B(+0.7%) |
| Mar 2005 | - | $3.17B(-9.4%) | $13.29B(-0.8%) |
| Dec 2004 | $13.39B(+1.1%) | $3.49B(+5.5%) | $13.39B(-0.1%) |
| Sep 2004 | - | $3.31B(-0.2%) | $13.41B(-1.0%) |
| Jun 2004 | - | $3.32B(+1.5%) | $13.54B(+0.3%) |
| Mar 2004 | - | $3.27B(-6.8%) | $13.50B(+1.9%) |
| Dec 2003 | $13.25B(+14.5%) | $3.51B(+1.9%) | $13.25B(+5.1%) |
| Sep 2003 | - | $3.44B(+5.1%) | $12.61B(+4.6%) |
| Jun 2003 | - | $3.28B(+8.5%) | $12.05B(+5.4%) |
| Mar 2003 | - | $3.02B(+5.2%) | $11.43B(-1.2%) |
| Dec 2002 | $11.57B(-7.7%) | $2.87B(-0.4%) | $11.57B(-1.1%) |
| Sep 2002 | - | $2.88B(+8.3%) | $11.71B(-2.5%) |
| Jun 2002 | - | $2.66B(-15.8%) | $12.01B(-5.5%) |
| Mar 2002 | - | $3.16B(+5.1%) | $12.71B(-1.9%) |
| Dec 2001 | $12.53B(-6.9%) | $3.00B(-5.6%) | $12.96B(+0.5%) |
| Sep 2001 | - | $3.18B(-5.3%) | $12.89B(-2.8%) |
| Jun 2001 | - | $3.36B(-1.3%) | $13.25B(-5.1%) |
| Mar 2001 | - | $3.41B(+16.0%) | $13.97B(-0.6%) |
| Dec 2000 | $13.46B(+3.4%) | $2.94B(-17.3%) | $14.06B(-4.2%) |
| Sep 2000 | - | $3.55B(-12.9%) | $14.68B(+2.5%) |
| Jun 2000 | - | $4.08B(+16.5%) | $14.32B(+2.5%) |
| Mar 2000 | - | $3.50B(-1.7%) | $13.97B(-1.5%) |
| Dec 1999 | $13.01B(+10.4%) | $3.56B(+11.5%) | $14.19B(+17.1%) |
| Sep 1999 | - | $3.19B(-14.2%) | $12.12B(-2.4%) |
| Jun 1999 | - | $3.72B(+0.2%) | $12.41B(+2.9%) |
| Mar 1999 | - | $3.72B(+150.6%) | $12.06B(+2.3%) |
| Dec 1998 | $11.79B(-8.1%) | $1.48B(-57.5%) | $11.79B(-14.3%) |
| Sep 1998 | - | $3.49B(+3.5%) | $13.75B(+2.3%) |
| Jun 1998 | - | $3.37B(-2.3%) | $13.44B(+2.0%) |
| Mar 1998 | - | $3.45B(+0.1%) | $13.18B(+2.7%) |
| Dec 1997 | $12.83B(+10.4%) | $3.44B(+8.3%) | $12.83B(+3.4%) |
| Sep 1997 | - | $3.18B(+2.5%) | $12.41B(+2.6%) |
| Jun 1997 | - | $3.10B(+0.0%) | $12.10B(+2.1%) |
| Mar 1997 | - | $3.10B(+2.4%) | $11.85B(+2.0%) |
| Dec 1996 | $11.62B(+9.8%) | $3.03B(+5.6%) | $11.62B(+1.3%) |
| Sep 1996 | - | $2.87B(+0.4%) | $11.47B(+2.7%) |
| Jun 1996 | - | $2.86B(-0.3%) | $11.17B(+2.1%) |
| Mar 1996 | - | $2.87B(-0.4%) | $10.93B(+3.4%) |
| Dec 1995 | $10.58B(+15.1%) | $2.88B(+11.9%) | $10.58B(+4.1%) |
| Sep 1995 | - | $2.57B(-2.0%) | $10.16B(+3.2%) |
| Jun 1995 | - | $2.62B(+4.5%) | $9.84B(+3.3%) |
| Mar 1995 | - | $2.51B(+2.1%) | $9.53B(+3.7%) |
| Dec 1994 | $9.19B(+5.7%) | $2.46B(+9.1%) | $9.19B(+2.2%) |
| Sep 1994 | - | $2.25B(-2.3%) | $8.99B(+0.9%) |
| Jun 1994 | - | $2.31B(+6.4%) | $8.91B(+1.7%) |
| Mar 1994 | - | $2.17B(-4.2%) | $8.77B(+0.9%) |
| Dec 1993 | $8.69B(+1.1%) | $2.26B(+4.0%) | $8.69B(+4.5%) |
| Sep 1993 | - | $2.17B(+0.6%) | $8.32B(-2.1%) |
| Jun 1993 | - | $2.16B(+3.5%) | $8.50B(-0.5%) |
| Mar 1993 | - | $2.09B(+10.5%) | $8.54B(-0.6%) |
| Dec 1992 | $8.59B(+1.4%) | $1.89B(-19.7%) | $8.59B(-3.8%) |
| Sep 1992 | - | $2.35B(+6.9%) | $8.93B(+2.8%) |
| Jun 1992 | - | $2.20B(+2.8%) | $8.69B(+1.6%) |
| Mar 1992 | - | $2.14B(-3.8%) | $8.55B(+0.9%) |
| Dec 1991 | $8.47B(+10.5%) | $2.23B(+5.7%) | $8.47B(+2.3%) |
| Sep 1991 | - | $2.11B(+1.9%) | $8.29B(+1.8%) |
| Jun 1991 | - | $2.07B(+0.1%) | $8.14B(+2.8%) |
| Mar 1991 | - | $2.07B(+1.3%) | $7.92B(+3.2%) |
| Dec 1990 | $7.67B(+14.0%) | $2.04B(+4.0%) | $7.67B(+36.2%) |
| Sep 1990 | - | $1.96B(+6.2%) | $5.63B(+53.5%) |
| Jun 1990 | - | $1.85B(+1.5%) | $3.67B(+101.5%) |
| Mar 1990 | - | $1.82B | $1.82B |
| Dec 1989 | $6.73B(+7.5%) | - | - |
| Dec 1988 | $6.26B(+15.5%) | - | - |
| Dec 1987 | $5.42B | - | - |
FAQ
- What is Bristol-Myers Squibb annual gross profit?
- What is the all time high annual gross profit for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual gross profit year-on-year change?
- What is Bristol-Myers Squibb quarterly gross profit?
- What is the all time high quarterly gross profit for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly gross profit year-on-year change?
- What is Bristol-Myers Squibb TTM gross profit?
- What is the all time high TTM gross profit for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM gross profit year-on-year change?
What is Bristol-Myers Squibb annual gross profit?
The current annual gross profit of BMY is $34.33B
What is the all time high annual gross profit for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual gross profit is $36.45B
What is Bristol-Myers Squibb annual gross profit year-on-year change?
Over the past year, BMY annual gross profit has changed by +$19.00M (+0.06%)
What is Bristol-Myers Squibb quarterly gross profit?
The current quarterly gross profit of BMY is $7.53B
What is the all time high quarterly gross profit for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly gross profit is $9.63B
What is Bristol-Myers Squibb quarterly gross profit year-on-year change?
Over the past year, BMY quarterly gross profit has changed by -$1.20B (-13.77%)
What is Bristol-Myers Squibb TTM gross profit?
The current TTM gross profit of BMY is $34.33B
What is the all time high TTM gross profit for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM gross profit is $37.39B
What is Bristol-Myers Squibb TTM gross profit year-on-year change?
Over the past year, BMY TTM gross profit has changed by +$19.00M (+0.06%)